Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nufola is a dietary supplement developed by Magna Pharmaceuticals, specifically formulated to provide nutritional support for individuals with small nerve fiber neuropathy and associated symptoms such as burning, tingling, and numbness. The product contains a combination of bioactive B-vitamins—L-methylfolate (3.5 mg), pyridoxal 5-phosphate (25 mg), and methylcobalamin (1 mg)—alongside the antioxidant alpha lipoic acid (300 mg). These ingredients are intended to support metabolic processes, enhance blood flow to peripheral nerves, and provide the necessary nutrients for nerve repair and maintenance. It is administered orally as a vegetarian capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nufola.